This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Hikma Pharmaceuticals PLC | 1,895.5 | 1.8% |
| GSK PLC | 1,576.2 | 1.8% |
| Severn Trent PLC | 2,604.0 | 1.5% |
| Smith & Nephew PLC | 1,086.0 | 1.5% |
| Scottish Mortgage Investment Trust PLC | 773.0 | 1.4% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Beazley PLC | 529.5 | -4.1% |
| JD Sports Fashion PLC | 114.8 | -3.9% |
| Ocado Group PLC | 713.4 | -2.9% |
| RS Group PLC | 765.8 | -2.6% |
| Endeavour Mining PLC | 1,504.0 | -2.3% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,686 | -0.1% | -0.5% |
| DOW JONES INDUS. AVG | 37,423 | -0.7% | 11.6% |
| DAX INDEX | 16,681 | -0.2% | 12.4% |
| NIKKEI 225 | 33,763 | 1.2% | 29.0% |
| S&P/ASX 200 INDEX | 7,521 | 0.9% | 5.5% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 71.62 | 1.20% |
| Brent Crude (ICE) | USD/bbl. | 76.98 | 1.13% |
| Gold Spot | USD/t oz. | 2,028 | 0.0% |
| Copper (Comex) | USd/lb. | 378 | -0.8% |
Click graph to enlarge
The UK 100 called to open -19 points at 7,664. The UK 100 is expected to open lower as investors await inflation figures in the US on Thursday for further clues as to the pace of interest rate cuts this year. Stateside yesterday saw the slow start to the year continue, the S&P closed lower by 0.15% to end at 4,756.50. At its lows of the day, the benchmark had dropped 0.7%. The Dow Jones lost 157.85 points, or 0.42%, to close at 37,525.16 after being down by roughly 310 points at the session lows. The Nasdaq recovered from a nearly 0.9% slide and eked out a gain of 0.09%, settling at 14,857.71.
Greggs report that their like-for-like sales rose 9.4% in Q4 as they saw high demand for seasonal products such as its festive bake and Christmas lunch baguette. They expect their FY results to be in line with previous expectations.
GSK says Nucala has been approved in China to treat severe eosinophilic asthma.
Pennon Group are to raise £180m in equity via placing of new shares in accelerated bookbuild. They have also purchased SES Water for £89m from Sumitomo and Osaka Gas.
Persimmon state that the housing market conditions would remain challenging in 2024, as broader economic woes continue to fuel affordability concerns. They have built 9,922 new homes in 2023, ahead of its previous forecast of 9,500 houses.
Sainsbury’s have kept their profit guidance for the FY after reporting a 7.4% rise in underlying sales for the key Christmas quarter. They expect their FY24 underlying pretax profit to be between £670-700m.
Smith & Nephew complete the acquisition of CartiHeal for $180m.
RBC Downgrades Capita Group to ‘Sector Perform’ from Outperform (3 Buys / 1 Hold / 0 Sells)
RBC Downgrades DCC to ‘Sector Perform’ from Outperform (8 Buys / 1 Hold / 0 Sells)
RBC Upgrades Compass Group to ‘Outperform’ from Sector Perform (10 Buys / 8 Holds / 0 Sells)
RBC Upgrades Intertek to ‘Outperform’ from Sector Perform (7 Buys / 7 Holds / 2 Sells)
RBC Upgrades IWG to ‘Outperform’ from Sector Perform (5 Buys / 2 Holds / 0 Sells)
UK
Greggs
Hunting
Persimmon
Sainsbury (J)
US
None
UK
Ferrexpo
Marks & Spencer Group
Taylor Wimpey
Tesco
Whitbread PLC
US
None
Oil Inventories
UK 100 companies going ex-dividend on 11th January 2023:
SSE
Sage Group
Ashtead Group
UK 250 companies going ex-dividend on 11th January 2023:
WH Smith
Foresight Group Holdings
AJ Bell
Balanced Commercial Property Trust
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.